[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335744-105":59,"doc-detail-335744-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pstat3-expression-is-increased-in-advanced-prostate-cancer-in-post-initiation-of-androgen-deprivation-therapy-original-article","pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post-Initiation of Androgen Deprivation Therapy - Original Article","","Signal Transducer and Activator of Transcription 3 (STAT3) drives multiple cancer-promoting processes, and its phosphorylated forms are implicated in advanced prostate cancer progression and therapy response. Using prostate tissue microarrays, pSTAT3Tyr705 and pSTAT3Ser727 were quantified by immunostaining in samples from patients before and after initiation of androgen deprivation therapy (ADT). Multivariable Cox regression assessed whether pSTAT3 signals predicted oncological outcomes under ADT, evaluating malignant epithelial and stromal compartments.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pstat3-expression-is-increased-in-advanced-prostate-cancer-in-post-initiation-of-androgen-deprivation-therapy-original-article/335744/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pstat3-expression-is-increased-in-advanced-prostate-cancer-in-post-initiation-of-androgen-deprivation-therapy-original-article/335744.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study aiming to determine about androgen deprivation therapy and pSTAT3?","Question",{"text":112,"@type":113},"The study determines how androgen deprivation therapy in advanced prostate cancer influences pSTAT3 expression in prostate cancer tissue.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were pSTAT3Tyr705 and pSTAT3Ser727 measured in this study?",{"text":117,"@type":113},"pSTAT3Tyr705 and pSTAT3Ser727 were assessed by immunostaining on a prostate tissue microarray, with H-score used to quantify intensity and percentage in malignant epithelial and stromal compartments.",{"name":119,"@type":110,"acceptedAnswer":120},"Which pSTAT3 marker was associated with worse outcomes after ADT?",{"text":121,"@type":113},"High cytoplasmic pSTAT3Ser727 in stromal compartments correlated with reduced overall survival and shorter time to castration-resistant prostate cancer, and multivariable analysis linked it to worse overall survival and poorer 5-year metastasis-free survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335744,1790169258,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","The Prostate  \nORIGINAL ARTICLE   \npSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy  \nPiotr Bialas1,2  | Tamae Kobayashi1 | Rebecka Hellsten1  | Agnieszka Krzyzanowska1  | Margareta Persson3 | Felicia Marginean1 | Dominique Trudel4,5 | Isla P. Garraway6,7 | Bruce J. Trock8 | Pekka Taimen9, 10 | Fred Saad11 | Tuomas Mirtti12, 13  | Beatrice Knudsen14 | Angelo M. De Marzo8, 15, 16 | Anders Bjartell1, 17   \n1Department of Translational Medicine, Division of Urological Cancers, Lund University, Malmö, Sweden | 2Chair and Department of Cell Biology, Poznan University of Medical Sciences, Poznan, Poland | 3Department of Laboratory Medicine, Translational Cancer Research, Lund University, Lund,  \nSweden | 4Centre de recherche du Centre hospitalier de l'Université de Montréal et Institut du cancer de Montréal, Montreal, Quebec, Canada | 5Department of Pathology and Cellular Biology, Université de Montréal, Montreal, Quebec, Canada | 6Department of Urology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California, Los Angeles, California, USA | 7Division of Urology, Greater Los Angeles VA Healthcare System, Los Angeles, California, USA | 8Department of Urology and Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA | 9Institute of Biomedicine and FICAN West Cancer Centre, University of Turku, Turku, Finland | 10Department of Pathology, Turku University Hospital, Turku, Finland | 11Department of Surgery, Université de Montréal, Montreal, Quebec, Canada | 12HUS Diagnostic Center, Department of Pathology, HUS Helsinki University Hospital, Helsinki, Finland | 13Medicum and Research Program In Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland | 14Digital and Computational Pathology, University of Utah, Salt Lake City, Utah, USA | 15Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA | 16Department of Oncology and The Sidney Kimmel Comprehensive Cancer Center at  \nJohns Hopkins, Baltimore, Maryland, USA | 17Department of Urology, Skåne University Hospital, Malmö, Sweden Correspondence: Anders Bjartell ([anders.bjartell@med.lu.se](anders.bjartell@med.lu.se))  \nReceived: 5 August 2024 | Revised: 14 October 2024 | Accepted: 23 October 2024  \nFunding: This work was supported by Swedish Scientific Council, ALF Lund University, Kungliga Fysiografiska Sallskapet i Lund, Movember Foundation, NIH/NCI SPORE, Fonds de Recherche du Québec‐Santé and Swedish Cancer Foundation.  \nKeywords: androgen deprivation therapy | androgens | biomarkers | prostate cancer | STAT3  \nABSTRACT  \nBackground: The transcription factor Signal Transducer and Activator of Transcription 3 (STAT3) plays a role in carcinogenesis and is involved in processes, such as proliferation, differentiation, drug resistance and immunosuppression. STAT3 can be activated by phosphorylation of tyrosine at position 705 (pSTAT3Tyr705) or serine at 727 (pSTAT3Ser727) . High expression levels of pSTAT3 are implicated in advanced stages of prostate cancer (PCa) and are known to interact with the androgen receptor signaling pathway. However, not much is known about how androgen deprivation therapy (ADT) in advanced disease affects pSTAT3 expression. The aim of this study was to determine the influence of ADT on pSTAT3 expression in PCa tissue. Methods: The study cohort came from a PCa tissue microarray resource containing prostate specimens from patients before and post‐initiation of ADT. Tissue samples from 111 patients were immunostained for pSTAT3Tyr705 and pSTAT3Ser727 . H‐score was used to evaluate the intensity and the percentage of pSTAT3 expression in malignant epithelial and stromal compartments. Univariate and multivariable Cox regression analyses were used to assess pSTAT3Tyr705 and pSTAT3Ser727 as biomarkers of oncological outcome in patients undergoing ADT.  \n\n| Abbrevi","cbCainsPMmq0I46C","https://ap.wps.com/l/cbCainsPMmq0I46C","pdf",1695144,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What is the study aiming to determine about androgen deprivation therapy and pSTAT3?\",\"answer\":\"The study determines how androgen deprivation therapy in advanced prostate cancer influences pSTAT3 expression in prostate cancer tissue.\"},{\"question\":\"How were pSTAT3Tyr705 and pSTAT3Ser727 measured in this study?\",\"answer\":\"pSTAT3Tyr705 and pSTAT3Ser727 were assessed by immunostaining on a prostate tissue microarray, with H-score used to quantify intensity and percentage in malignant epithelial and stromal compartments.\"},{\"question\":\"Which pSTAT3 marker was associated with worse outcomes after ADT?\",\"answer\":\"High cytoplasmic pSTAT3Ser727 in stromal compartments correlated with reduced overall survival and shorter time to castration-resistant prostate cancer, and multivariable analysis linked it to worse overall survival and poorer 5-year metastasis-free survival.\"}]","pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post-Initiation of Androgen Deprivation Therapy - Original Article | PDF",1790012188,33]